EMIT 2000 N-ACETYLPROCAINAMIDE ASSAY, MODEL OSR4N229— 510(k) K011620

Name: FDA 510(k) clearance K011620
Creator: U.S. Food and Drug Administration
Published: 2001-06-18

Substantially Equivalent

Syva Co., Dade Behring, Inc.

FDA 510(k) clearance K011620 for EMIT 2000 N-ACETYLPROCAINAMIDE ASSAY, MODEL OSR4N229, Substantially Equivalent on 2001-06-18. Applicant: Syva Co., Dade Behring, Inc.. Device class: 2.

Clearance details

Applicant: Syva Co., Dade Behring, Inc.
Product code: Code LAN
Device class: Class 2
Regulation: 21 CFR 862.3320
Advisory panel: Clinical Toxicology
Date received: 2001-05-25
Decision date: 2001-06-18
Decision: Substantially Equivalent
Clearance type: Special
Location: San Jose, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LAN

view all

K060738 — TDM N-ACETYLPROCAINAMIDE2006-08-16
K032564 — DIMENSION N-ACETYLPROCAINAMIDE (NAPA) FLEX REAGENT CARTRIDGE METHOD, MODEL DF1112003-10-31
K983812 — NAPA EIA ASSAY1998-11-16
K971713 — N-ACETYLPROCAINAMIDE ASSAY FOR THE BAYER IMMUNO 1 SYSTEM1997-06-11
K955422 — AXSYM N-ACETYLPROCAINAMIDE1996-04-24

More clearances from Syva Co., Dade Behring, Inc.

view all

K011920 — EMIT 2000 DIGOXIN ASSAY, MODEL OSR4H2292001-07-02
K011605 — EMIT 2000 QUINIDINE ASSAY, MODEL OSR4Q2292001-06-12
K011300 — EMIT II PLUS CANNABINOID ASSAY, MODEL OSR9N2292001-05-17
K011306 — EMIT II PLUS BENZODIAZEPINE ASSAY, MODEL 0SR9F2292001-05-16
K011161 — MODIFICATION TO THE EMIT II PLUS PHENCYCLIDINE ASSAY, MODEL OSR9J2292001-05-15

Data sourced from openFDA. This site is unofficial and independent of the FDA.